Cargando…

Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis

INTRODUCTION: The present study aimed to evaluate leprosy cure and relapse rates as primary outcomes related to two additional strategies for leprosy treatment: clofazimine for paucibacillary (PB) leprosy patients and clarithromycin for patients with rifampicin-resistant leprosy. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montezuma, Thais, Vernal, Sebastian, Andrade, Elaine Nascimento, Brandão, Jurema Guerrieri, de Oliveira, Gustavo Laine Araújo, Gomes, Ciro Martins
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206035/ https://www.ncbi.nlm.nih.gov/pubmed/37234244 http://dx.doi.org/10.3389/fmed.2023.1139304

Ejemplares similares

Morphea Simulating Paucibacillary Leprosy Clinically and Histopathologically
por: Delgado, José Saulo Torres, et al.
Publicado: (2013)

Clofazimine induced pigmentation in leprosy patches
por: Chavhan, Samiksha Deepak, et al.
Publicado: (2022)

Diagnostic challenges of single plaque-like lesion paucibacillary leprosy
por: Barbieri, Raquel Rodrigues, et al.
Publicado: (2014)

Study of S100 Immunostaining in Demonstrating Neural Granulomas in Paucibacillary Leprosy
por: Shenoy, Nandini, et al.
Publicado: (2018)

Clofazimine-induced enteropathy in a patient of leprosy
por: Singh, Harminder, et al.
Publicado: (2013)

Altered cytokine profiles in relapsed paucibacillary leprosy: a case report
por: Sameshima, Tomoyuki, et al.
Publicado: (2021)

Quantitative polymerase chain reaction in paucibacillary leprosy diagnosis: A follow-up study
por: Barbieri, Raquel R., et al.
Publicado: (2019)

BACTERIOLOGICAL STUDY OF AEROBIC ISOLATES FROM PLANTAR ULCERS OF PAUCIBACILLARY LEPROSY PATIENTS
por: Majumdar, Monalisa, et al.
Publicado: (2010)

Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines
por: Lockwood, Diana N. J., et al.
Publicado: (2019)

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study
por: Kumar, Anil, et al.
Publicado: (2012)

Response to “Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines”
por: Kumar, Bhushan, et al.
Publicado: (2020)

Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme()
por: Pennini, Silmara Navarro, et al.
Publicado: (2022)

Clinical and Histopathological Response to Multidrug Therapy in Paucibacillary Leprosy at the end of 6 Months: A Prospective Observational Study from Eastern India
por: Podder, Indrashis, et al.
Publicado: (2018)

Development and evaluation of a droplet digital PCR assay for the diagnosis of paucibacillary leprosy in skin biopsy specimens
por: Cheng, Xiujun, et al.
Publicado: (2019)

Clinical and Histopathological Response to Multidrug Therapy in Paucibacillary Leprosy at the End of 6 Months: A Prospective Observational Study from Eastern India - a comment
por: Nair, Pragya Ashok, et al.
Publicado: (2018)

Standardization of SYBR Green-Based Real-Time PCR Through the Evaluation of Different Thresholds for Different Skin Layers: An Accuracy Study and Track of the Transmission Potential of Multibacillary and Paucibacillary Leprosy Patients
por: Sevilha-Santos, Lais, et al.
Publicado: (2021)

Association of CD209 (DC-SIGN) rs735240 SNV with paucibacillary leprosy in the Brazilian population and its functional effects
por: Germano, Giovanna Valle, et al.
Publicado: (2022)

Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient
por: Barot, Rakesh K, et al.
Publicado: (2011)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Utility of Multi-target Nested PCR and ELISPOT Assays for the Detection of Paucibacillary Leprosy: A Possible Conclusion of Clinical Laboratory Misdiagnosis
por: Jiang, Haiqin, et al.
Publicado: (2022)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
por: Anderson, Ronald, et al.
Publicado: (2018)

Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist’s dilemma
por: Parajuli, Niraj, et al.
Publicado: (2021)

Primary Multidrug-Resistant Leprosy, United States
por: Williams, Diana Lynn, et al.
Publicado: (2013)

Multidrug-resistant tuberculosis and leprosy: An unsolved mystery
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Multidrug-resistant tuberculosis and leprosy: An unsolved mystery
por: Gupta, Robin, et al.
Publicado: (2017)

Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China
por: Chen, Xiaohua, et al.
Publicado: (2019)

Neutrophils in Leprosy
por: Schmitz, Veronica, et al.
Publicado: (2019)

Clofazimine/dapsone/rifampicin: Lepra reactions: 3 case reports
Publicado: (2021)

Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people’s Republic of China
por: Yu, Meiwen, et al.
Publicado: (2013)

Progressive neuropathy in patients with lepromatous leprosy after multidrug therapy
por: Penna, Patricia Sola, et al.
Publicado: (2023)

COVID-19, leprosy, and neutrophils
por: Schmitz, Veronica, et al.
Publicado: (2021)

Histoid leprosy: a rare exuberant case
por: de Andrade, Pedro Jose Secchin, et al.
Publicado: (2015)

International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes
por: Manickam, Ponnaiah, et al.
Publicado: (2016)

Uniform multidrug therapy for leprosy – time for a rethink?
por: Saunderson, Paul R.
Publicado: (2016)

Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells
por: Kumar, Harish, et al.
Publicado: (2020)

Visual processing of color and shape in people with leprosy: Visual processing in people with leprosy
por: Soares, Perla Figueredo Carreiro, et al.
Publicado: (2020)

LEPROSY
Publicado: (1946)

Leprosy
por: Marcos, Luis A., et al.
Publicado: (2014)

Leprosy
Publicado: (1925)

Cannot write session to /tmp/vufind_sessions/sess_4fsjfh4cqbpvv6ek77sl0hl4ou